CYP7A1 and diabetes mellitus: As shown in Figure 6, compared with the DM model group, the gene expressions and protein levels of Cyp7a1 in the pioglitazone-treated group were significantly decreased, while the gene expression level of Cp in the pioglitazone-treated group was also significantly downregulated after treatment with pioglitazone for 11 weeks.